BPMUF
Price
$67.75
Change
+$6.41 (+10.45%)
Updated
Jul 30 closing price
Capitalization
713.76M
GTBP
Price
$0.75
Change
-$0.01 (-1.32%)
Updated
Sep 26, 01:58 PM (EDT)
Capitalization
2.71M
Interact to see
Advertisement

BPMUF vs GTBP

Header iconBPMUF vs GTBP Comparison
Open Charts BPMUF vs GTBPBanner chart's image
Basilea Pharmaceutica AG
Price$67.75
Change+$6.41 (+10.45%)
Volume$15
Capitalization713.76M
GT Biopharma
Price$0.75
Change-$0.01 (-1.32%)
Volume$100
Capitalization2.71M
BPMUF vs GTBP Comparison Chart in %
Loading...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMUF vs. GTBP commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMUF is a Buy and GTBP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BPMUF: $67.75 vs. GTBP: $0.76)
Brand notoriety: BPMUF and GTBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMUF: 107% vs. GTBP: 71%
Market capitalization -- BPMUF: $713.76M vs. GTBP: $2.71M
BPMUF [@Biotechnology] is valued at $713.76M. GTBP’s [@Biotechnology] market capitalization is $2.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMUF’s FA Score shows that 2 FA rating(s) are green whileGTBP’s FA Score has 1 green FA rating(s).

  • BPMUF’s FA Score: 2 green, 3 red.
  • GTBP’s FA Score: 1 green, 4 red.
According to our system of comparison, BPMUF is a better buy in the long-term than GTBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMUF’s TA Score shows that 1 TA indicator(s) are bullish while GTBP’s TA Score has 6 bullish TA indicator(s).

  • BPMUF’s TA Score: 1 bullish, 0 bearish.
  • GTBP’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, GTBP is a better buy in the short-term than BPMUF.

Price Growth

BPMUF (@Biotechnology) experienced а 0.00% price change this week, while GTBP (@Biotechnology) price change was -6.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMUF($714M) has a higher market cap than GTBP($2.71M). BPMUF YTD gains are higher at: 28.242 vs. GTBP (-75.049). BPMUF has higher annual earnings (EBITDA): 77.9M vs. GTBP (-9.61M). BPMUF has more cash in the bank: 128M vs. GTBP (5.23M). GTBP has less debt than BPMUF: GTBP (0) vs BPMUF (96.8M). BPMUF has higher revenues than GTBP: BPMUF (236M) vs GTBP (0).
BPMUFGTBPBPMUF / GTBP
Capitalization714M2.71M26,376%
EBITDA77.9M-9.61M-811%
Gain YTD28.242-75.049-38%
P/E Ratio9.79N/A-
Revenue236M0-
Total Cash128M5.23M2,448%
Total Debt96.8M0-
FUNDAMENTALS RATINGS
BPMUF vs GTBP: Fundamental Ratings
BPMUF
GTBP
OUTLOOK RATING
1..100
4117
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
63100
SMR RATING
1..100
12100
PRICE GROWTH RATING
1..100
4697
P/E GROWTH RATING
1..100
25100
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTBP's Valuation (14) in the null industry is somewhat better than the same rating for BPMUF (73). This means that GTBP’s stock grew somewhat faster than BPMUF’s over the last 12 months.

BPMUF's Profit vs Risk Rating (63) in the null industry is somewhat better than the same rating for GTBP (100). This means that BPMUF’s stock grew somewhat faster than GTBP’s over the last 12 months.

BPMUF's SMR Rating (12) in the null industry is significantly better than the same rating for GTBP (100). This means that BPMUF’s stock grew significantly faster than GTBP’s over the last 12 months.

BPMUF's Price Growth Rating (46) in the null industry is somewhat better than the same rating for GTBP (97). This means that BPMUF’s stock grew somewhat faster than GTBP’s over the last 12 months.

BPMUF's P/E Growth Rating (25) in the null industry is significantly better than the same rating for GTBP (100). This means that BPMUF’s stock grew significantly faster than GTBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMUFGTBP
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
19%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
15%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
8%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMRRX35.42N/A
N/A
BlackRock Mid-Cap Growth Equity R
UEPSX19.63N/A
N/A
ProFunds Europe 30 Svc
MVALX43.65N/A
N/A
Meridian Contrarian Legacy
TASCX20.54N/A
N/A
Third Avenue Small Cap Value Instl
PENNX9.54-0.11
-1.14%
Royce Small-Cap Fund Invmt

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
-0.84%
GTBP - BPMUF
29%
Poorly correlated
-4.86%
NCNA - BPMUF
28%
Poorly correlated
-4.10%
More